PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1410583
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1410583
The global respiratory care devices market is poised for substantial growth, with projections indicating an increase from US$ 20 billion in 2024 to a staggering US$ 40 billion by the end of 2031.
Respiratory care devices play a pivotal role in the treatment, management, diagnosis, and care of patients with cardiopulmonary abnormalities. These devices are especially vital in addressing chronic obstructive pulmonary diseases (COPD), including chronic bronchitis and emphysema, which are leading causes of global mortality. The market is witnessing significant growth due to the rising incidence of chronic pulmonary obstructive diseases, technological innovations, and a robust product pipeline.
North America is poised to dominate the global respiratory care devices market, followed by Europe. These regions benefit from highly developed healthcare infrastructures, a substantial patient pool affected by respiratory diseases due to lifestyle factors like tobacco use, and easy access to trained personnel proficient in operating advanced respiratory devices.
Respiratory care devices constitute a critical segment of medical devices dedicated to treating, managing, diagnosing, and caring for patients with cardiopulmonary system abnormalities. These devices play a crucial role in addressing chronic obstructive pulmonary diseases (COPD), a leading cause of mortality worldwide.
Leading players in the global respiratory care devices market include: Philips Healthcare (Netherlands), Masimo Corporation (U.S.), Fisher and Paykel Healthcare Limited (New Zealand), ResMed, Inc. (U.S.), Covidien plc (Ireland), and CareFusion Corporation (U.S.).